6-Bromo-7-methoxy-1,1-dimethyl-3,4-dihydronaphthalen-2(1H)-one, 97%, 1g

4-Phenylquinazolin-2(1H)-one, 95.0%, 250mg

2-AMINO-6-BOC-3-CARBAMOYL-4,5-DIHYDROTHIENO[2,3-C]PYRIDINE, 97.0%, 5g

1-((6-Chloropyridin-3-yl)methyl)piperazine dihydrochloride, 95.0%, 5g

1-Bromo-3-phenoxybenzene>97.0%(GC)1g

Lithium Chloride (2.3% in Tetrahydrofuran, ca. 0.5mol/L)100mL

4'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1'-biphenyl]-4-ol, 98%, 200mg

1-Ethyl-3-methylpyrazole-5-carbonyl chloride, 95.0%, 1g

N-Benzylnaphthalen-2-amine, 98%, 10g

BENZYL 3-CARBAMOYLPROPYLMETHYLCARBAMATE, 95.0%, 1g

Boc-D-Dab(Z)(ol), 99.0%, 1g

4,6-BIS((S)-4-(TERT-BUTYL)-4,5-DIHYDROOXAZOL-2-YL)DIBENZO[B,D]FURAN, 95%, 250mg

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 30 m, Ø-Innen 0,53 mm, Filmd. 1,00 µm, 1 Stück